BIOSERGEN AB
BIOSERGEN AB
Share · SE0016013460 · A3CSG0 (XSTO)
Overview
No Price
Closing Price XSTO 31.10.2025: 0,47 SEK
31.10.2025 11:31
Current Prices from BIOSERGEN AB
ExchangeTickerCurrencyLast TradePriceDaily Change
XSTO: NASDAQ STOCKHOLM AB
NASDAQ STOCKHOLM AB
BIOSGN.ST
SEK
31.10.2025 11:31
0,47 SEK
0,007 SEK
+1,51 %
Share Float & Liquidity
Free Float 57,73 %
Shares Float 135,57 M
Shares Outstanding 234,82 M
Company Profile for BIOSERGEN AB Share
Biosergen AB, a biopharmaceutical company, engages in the development of antifungal products. It is developing BSG005, an antifungal drug candidate for the treatment of life threatening invasive fungal diseases. The company was founded in 2004 and is headquartered in Solna, Sweden.
Get up to date insights from finAgent about BIOSERGEN AB

Company Data

Name BIOSERGEN AB
Company Biosergen AB
Website https://biosergen.net
Primary Exchange XSTO Frankfurt
WKN A3CSG0
ISIN SE0016013460
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Tine Kold Olesen
Market Capitalization 116 Mio
Country Sweden
Currency EUR
Employees 0,0 T
Address Fogdevreten 2, 171 65 Solna
IPO Date 2021-06-24

Ticker Symbols

Name Symbol
NASDAQ STOCKHOLM AB BIOSGN.ST
Frankfurt 8N1.F
More Shares
Investors who hold BIOSERGEN AB also have the following shares in their portfolio:
LYXOR MSCI EMERGING MARKETS (LUX)
LYXOR MSCI EMERGING MARKETS (LUX) ETF
URW 20/27 MTN
URW 20/27 MTN Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025